Send the following on WhatsApp
Continue to ChatStudy of Lu-177-DOTATATE (Lutathera) in Combination With PARP Inhibitors in Inoperable/Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) https://ronnyallan.net/2022/10/06/phase-i-ii-study-of-lu-177-dotatate-lutathera-in-combination-with-olaparib-in-inoperable-gastroenteropancreatico-neuroendocrine-tumors-gep-net/